Since 2008, no data on HIV diversity or the transmission rate of HIV resistance mutations in naive patients have been presented for Algeria, a country of MENA region. Between 2013 and 2014, we studied 152 samples including 89 naive patients. The current study describes the change in HIV diversity in Algeria with the predominance of CRF06_cpx and the huge increase of transmitted HIV resistance, which now reaches 15%.
Get full access to this article
View all access options for this article.
References
1.
MumtazGR, WeissHA, ThomasSL, et al.: HIV among people who inject drugs in the Middle East and North Africa: Systematic review and data synthesis. PLoS Med, 2014; 11(6):e1001663.
2.
BozicevicI, RiednerG, and CallejaJMG: HIV surveillance in MENA: Recent developments and results. Sex Transm Infect, 2013; 89:iii11–iii16.
3.
/www.unaids.org/Fact Sheet 2014 (PDF).
4.
Ministère de la Santé de la Population et de la Réforme Hospitalière. Rapport d'activité sur la riposte nationale au VIH/sida en Algérie, 2014.
5.
BouzeghoubS, JauvinV, Recordon-PinsonP, et al.: High diversity of HIV type 1 in Algeria. AIDS Res Hum Retroviruses, 2006; 22(4):367–372.
6.
BouzeghoubS, JauvinV, PinsonP, et al.: First observation of HIV type 1 drug resistance mutations in Algeria. AIDS Res Hum Retroviruses, 2008; 24(11):1467–1473.
7.
MarechalV, JauvinV, SelekonB, et al.: Increasing HIV type 1 polymorphic diversity but no resistance to antiretroviral drugs in untreated patients from Central African Republic: A 2005 study. AIDS Res Hum Retroviruses, 2006; 22(10):1036–1044.
8.
LetunicI and BorkP: Interactive Tree of Life v2: Online annotation and display of phylogenetic trees made easy. Nucleic Acids Res, 2011; 39:W475–478.
9.
SsemwangaD, LihanaRW, UgojiC, et al.: Update on HIV-1 acquired and transmitted drug resistance in Africa. AIDS Rev, 2015; 17(1):3–20.
10.
PereiraNR, DuroR, PiñeroC, et al.: Primary drug resistance at diagnosis of HIV-1 infection: A Portuguese cohort. J Int AIDS Soc, 2014; 17(4 Suppl 3):19761.
11.
ZengP, LiuY, HeM, et al.: HIV-1 genotypic diversity and prevalence of drug resistance among treatment naïve HIV-infected individuals in Chengdu of China. Virus Genes, 2013; 47(3):408–413.
12.
BennettDE, CamachoRJ, OteleaD, et al.: drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One, 2009; 4(3):e4724.
